Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complete myocardial revascularization: between myth and reality.

Marco Zimarino1, Antonio Maria Calafiore, Raffaele De Caterina

  • 1Institute of Cardiology and Centre of Excellence on Aging, 'G. d'Annunzio' University, Ospedale S. Camillo de Lellis, Via Forlanini, 50, 66100 Chieti, Italy. m.zimarino@unich.it

European Heart Journal
|April 13, 2005
PubMed
Summary

Complete myocardial revascularization offers long-term benefits but carries higher immediate risks. Incomplete revascularization may be preferred in select patients due to lower risks, guided by clinical status and comorbidities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry.

JACC. Advances·2026
Same author

Potentially futile outcome after uncomplicated TAVI: Insights from the TRITAVI registry.

American heart journal·2026
Same author

Prognostic Impact of Neurologic Events After Transcatheter Aortic Valve Implantation According to Their Timing.

The Canadian journal of cardiology·2026
Same author

Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve Implantation.

Circulation. Cardiovascular interventions·2026
Same author

Adrenaline, Takotsubo Cardiomyopathy, Anaphylaxis, and Kounis Syndrome (ATAK) Complex: Clinical Phenotypes, Differential Diagnosis, and Management.

JACC. Case reports·2026
Same author

Prophylactic IABP in patients with severe ventricular dysfunction undergoing CABG: impact on early postoperative outcomes.

Journal of cardiothoracic surgery·2026

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Multi-vessel coronary artery disease (CAD) management involves strategic decisions regarding the extent of revascularization.
  • Treatment options include percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
  • The choice between complete versus incomplete revascularization significantly impacts treatment strategy and patient outcomes.

Purpose of the Study:

  • To analyze the implications of complete versus incomplete myocardial revascularization in patients with multi-vessel coronary artery disease.
  • To evaluate the trade-offs between potential long-term benefits and immediate risks associated with different revascularization extents.
  • To identify patient-specific factors influencing the decision for incomplete revascularization.

Related Experiment Videos

Main Methods:

  • Review of treatment strategies for multi-vessel coronary artery disease.
  • Comparison of outcomes associated with complete myocardial revascularization versus incomplete revascularization.
  • Analysis of factors influencing the choice of revascularization extent, including patient clinical status, ventricular function, and comorbidities.

Main Results:

  • Complete myocardial revascularization aims for long-term benefits but is associated with increased complexity and potential in-hospital adverse events.
  • Incomplete revascularization, while potentially impacting long-term outcomes, offers lower immediate risks and may be a preferred strategy in selected patients.
  • Clinical status, ventricular function, and comorbidities are key determinants in opting for incomplete revascularization.

Conclusions:

  • The extent of planned myocardial revascularization is a critical determinant in managing multi-vessel coronary artery disease.
  • Incomplete revascularization can be a judiciously chosen strategy in specific patient populations to mitigate immediate procedural risks.
  • Personalized treatment decisions, considering both procedural risks and long-term benefits, are essential for optimal patient care in multi-vessel CAD.